Myocardial tissue engineering: the quest for the ideal myocardial substitute

References

• Braunwald E. Shattuck lecture – cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med.337(19), 1360–1369 (1997).
   PubMed Web of Science ®Google Scholar
• Koerner MM, Durand JB, Lafuente JA, Noon GP, Torre-Amione G. Cardiac transplantation: the final therapeutic option for the treatment of heart failure. Curr. Opin. Cardiol.15(3), 178–182 (2000).
   PubMed Web of Science ®Google Scholar
• Gardner RS, McDonagh TA. The treatment of chronic heart failure due to left ventricular systolic dysfunction. Clin. Med.4(1), 18–22 (2004).
   PubMed Web of Science ®Google Scholar
• Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J. Heart Lung Transplant.19(10), 909–931 (2000).
   PubMed Web of Science ®Google Scholar
• Hunt SA. Current status of cardiac transplantation. JAMA280(19), 1692–1698 (1998).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc. Med.17(4), 134–140 (2007).
   PubMed Web of Science ®Google Scholar
• Kofidis T, de Bruin JL, Hoyt G et al. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J. Heart Lung Transplant.24(6), 737–744 (2005).
   PubMed Web of Science ®Google Scholar
• Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ. Res.98(8), 1002–1013 (2006).
   PubMed Web of Science ®Google Scholar
• Kehat I, Gepstein L. Human embryonic stem cells for myocardial regeneration. Heart Fail. Rev.8(3), 229–236 (2003).
   PubMed Web of Science ®Google Scholar
• Muller-Ehmsen J, Whittaker P, Kloner RA et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol.34(2), 107–116 (2002).
   PubMed Web of Science ®Google Scholar
• Vacanti CA. The history of tissue engineering. J. Cell. Mol. Med.10(3), 569–576 (2006).
   PubMed Web of Science ®Google Scholar
• Lalan S, Pomerantseva I, Vacanti JP. Tissue engineering and its potential impact on surgery. World J. Surg.25(11), 1458–1466 (2001).
   PubMed Web of Science ®Google Scholar
• Kofidis T, Lee CN. From vision to mission in myocardial restoration. Asian Cardiovasc. Thorac. Ann.16(2), 91–92 (2008).
   PubMedGoogle Scholar
• Buckberg GD. Basic science review: the helix and the heart. J. Thorac. Cardiovasc. Surg.124(5), 863–883 (2002).
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. The immune system and cardiac repair. Pharmacol. Res.58(2), 88–111 (2008).
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation81(4), 1161–1172 (1990).
   PubMed Web of Science ®Google Scholar
• White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation76(1), 44–51 (1987).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH. Remuscularizing failing hearts with tissue engineered myocardium. Antioxid. Redox Signal.11(8), 2011–2023 (2009).
   PubMed Web of Science ®Google Scholar
• Caspi O, Lesman A, Basevitch Y et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res.100(2), 263–272 (2007).
   PubMed Web of Science ®Google Scholar
• Birla RK, Borschel GH, Dennis RG, Brown DL. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng.11(5–6), 803–813 (2005).
   PubMedGoogle Scholar
• Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med.12(4), 452–458 (2006).
   PubMed Web of Science ®Google Scholar
• Kelm JM, Djonov V, Hoerstrup SP et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng.12(9), 2541–2553 (2006).
   PubMedGoogle Scholar
• Shimizu T, Yamato M, Isoi Y et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res.90(3), e40 (2002).
   PubMed Web of Science ®Google Scholar
• Sekine H, Shimizu T, Hobo K et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation118(14 Suppl.), S145–S152 (2008).
   PubMed Web of Science ®Google Scholar
• Sekiya S, Shimizu T, Yamato M, Kikuchi A, Okano T. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem. Biophys. Res. Commun.341(2), 573–582 (2006).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Sekine H, Isoi Y, Yamato M, Kikuchi A, Okano T. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng.12(3), 499–507 (2006).
   PubMedGoogle Scholar
• Shimizu T, Sekine H, Yang J et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J.20(6), 708–710 (2006).
   PubMed Web of Science ®Google Scholar
• Leor J, Aboulafia-Etzion S, Dar A et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation102(19 Suppl. 3), III56–III61 (2000).
   PubMed Web of Science ®Google Scholar
• Piao H, Kwon JS, Piao S et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials28(4), 641–649 (2007).
   PubMed Web of Science ®Google Scholar
• Kellar RS, Landeen LK, Shepherd BR, Naughton GK, Ratcliffe A, Williams SK. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation104(17), 2063–2068 (2001).
   PubMed Web of Science ®Google Scholar
• Simpson D, Liu H, Fan TH, Nerem R, Dudley SC Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells25(9), 2350–2357 (2007).
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature410(6829), 701–705 (2001).
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature428(6983), 668–673 (2004).
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature428(6983), 664–668 (2004).
   PubMed Web of Science ®Google Scholar
• Naito H, Melnychenko I, Didie M et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation114(1 Suppl.), I72–I78 (2006).
   PubMed Web of Science ®Google Scholar
• Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med.12(4), 459–465 (2006).
   PubMed Web of Science ®Google Scholar
• Bartosh TJ, Wang Z, Rosales AA, Dimitrijevich SD, Roque RS. 3D-model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress. J. Cell. Biochem.105(2), 612–623 (2008).
   PubMed Web of Science ®Google Scholar
• Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol.22(4), 195–202 (2004).
   PubMed Web of Science ®Google Scholar
• Tan MY, Zhi W, Wei RQ et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials30(19), 3234–3240 (2009).
   PubMed Web of Science ®Google Scholar
• Wei HJ, Chen CH, Lee WY et al. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials29(26), 3547–3556 (2008).
   PubMed Web of Science ®Google Scholar
• Chen CH, Wei HJ, Lin WW et al. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovasc. Res.80(1), 88–95 (2008).
   PubMed Web of Science ®Google Scholar
• Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med.14(2), 213–221 (2008).
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy L. Surgical treatment of cardiac ischemia. Lancet232, 185–194 (1937).
   Google Scholar
• Ueyama K, Bing G, Tabata Y et al. Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology. J. Thorac. Cardiovasc. Surg.127(6), 1608–1615 (2004).
   PubMed Web of Science ®Google Scholar
• Shao ZQ, Kawasuji M, Takaji K, Katayama Y, Matsukawa M. Therapeutic angiogenesis with autologous hepatic tissue implantation and omental wrapping. Circ. J.72(11), 1894–1899 (2008).
   PubMed Web of Science ®Google Scholar
• Birla RK, Dhawan V, Dow DE, Huang YC, Brown DL. Cardiac cells implanted into a cylindrical, vascularized chamber in vivo: pressure generation and morphology. Biotechnol. Lett.31(2), 191–201 (2009).
   PubMed Web of Science ®Google Scholar
• Morritt AN, Bortolotto SK, Dilley RJ et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation115(3), 353–360 (2007).
   PubMed Web of Science ®Google Scholar
• Hoffman RM. To do tissue culture in two or three dimensions? That is the question. Stem Cells11(2), 105–111 (1993).
   PubMed Web of Science ®Google Scholar
• Eschenhagen T, Fink C, Remmers U et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J.11(8), 683–694 (1997).
   PubMed Web of Science ®Google Scholar
• Freed LE, Vunjak-Novakovic G. Microgravity tissue engineering. In Vitro Cell. Dev. Biol. Anim.33(5), 381–385 (1997).
   PubMed Web of Science ®Google Scholar
• Hoerstrup SP, Zund G, Schnell AM et al. Optimized growth conditions for tissue engineering of human cardiovascular structures. Int. J. Artif. Organs23(12), 817–823 (2000).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Schneiderbanger K, Schubert P et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res.90(2), 223–230 (2002).
   PubMed Web of Science ®Google Scholar
• Radisic M, Park H, Gerecht S, Cannizzaro C, Langer R, Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci.362(1484), 1357–1368 (2007).
   PubMed Web of Science ®Google Scholar